Chile Sees Win On Sensitive TPP IP Provisions Such As Biologics, Linkage
The Chilean government is claiming victory on at least three controversial issues in the intellectual property (IP) chapter of the Trans-Pacific Partnership (TPP) for which it says it will not need to change its current law to comply with the agreement's obligations. The three issues, which the Chilean government had long identified as among its biggest sensitivities in the TPP talks, are the exclusivity period for biologic drugs; patent linkage for pharmaceuticals; and the procedures for Internet service providers (ISPs)...